LMS forms risk and patient safety advisory board
May 04 2005 - 9:35AM
PR Newswire (US)
LMS forms risk and patient safety advisory board MONTREAL, May 4
/PRNewswire-FirstCall/ -- LMS Medical Systems (AMEX:LMZ; TSX:LMZ),
a healthcare technology company and developer of the CALM(TM)
system (Computer Assisted Labor Management), today announced the
creation of the LMS Risk and Patient Safety Advisory Board and the
appointment of Dr. Thomas J. Garite and Mr. Harry G. Hohn to the
Board. Obstetrics has become one of the most litigated areas in
healthcare. A comprehensive approach involving hospital
administrators, clinicians, risk managers and insurers is needed to
address this issue and improve patient safety and clinical
outcomes. While each of these stakeholders plays a specific role in
the obstetrical spectrum, all must work together in order to build
effective risk reduction strategies. The Risk and Patient Safety
Advisory Board will provide guidance to LMS on how to achieve
widespread adoption of its sophisticated risk management tools in
obstetrics. This will include strategies to mobilize hospital teams
to implement proactive risk reduction programs and to develop value
propositions that address the concerns of the various stakeholders.
Dr. Garite is Professor Emeritus in the Department of Obstetrics
and Gynecology at the University of California, Irvine. He is
Editor in Chief of the American Journal of Obstetrics and
Gynecology. His research interests have focused largely on
intrapartum fetal monitoring and premature delivery. Dr. Garite has
published over 120 articles and chapters and 3 books. He is a past-
president of the Society of Perinatal Obstetricians, and a member
of the Society of Gynecologic Investigation, as well as numerous
other distinguished societies. Mr. Harry Hohn, a lawyer and member
of the LMS Board of Directors, is well known throughout the US
insurance industry having guided the New York Life Insurance
Company where he served as Chief Executive Officer and Chairman of
the Board. Mr. Hohn has also served as the head of a number of
national insurance groups and charitable organizations. Mr. Hohn
will chair the Advisory Board for the first year of its activities.
LMS specializes in risk management tools for clinicians and
managers. The CALM tools incorporate statistical processes to
quantify normal and abnormal labor progression as well as digital
signal processing and neural network applications for the
identification of abnormal fetal heart rate patterns. The CALM
Curve provides for consistent and objective assessment of the labor
progress at the bedside. CALM Patterns provides objective,
real-time measurement and classification of fetal heart rate
patterns. These tools address themes commonly found in adverse
outcomes namely, failure to recognize and respond to abnormal
tracings and prolonged labor. "Dr. Garite and Mr. Hohn bring
exceptional expertise and experience to the challenge of improving
care in today's healthcare system." said Diane Cote, President and
CEO of LMS. "We are pleased to have them join in our efforts to
deliver tools that assist clinicians in the improvement of care and
patient safety while reducing risk." About LMS: LMS is a leader in
the application of advanced mathematical modeling and neural
networks for medical use. The LMS Computer Assisted Labor
Management product suite provides physicians, nursing staff and
risk managers with innovative obstetrical decision support and risk
management tools integrated into robust clinical information
systems designed to improve outcomes and patient care for mothers
and their infants during labor and delivery. This press release
contains forward-looking statements that involve risks and
uncertainties, which may cause actual results to differ materially
from the statements made. For this purpose, any statements that are
contained herein that are not statements of historical fact may be
deemed to be forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Without limiting the foregoing, the words "believes,"
"anticipates," "plans," "intends," "will," "should," "expects,"
"projects," and similar expressions are intended to identify
forward-looking statements. You are cautioned that such statements
are subject to a multitude of risks and uncertainties that could
cause actual results, future circumstances, or events to differ
materially from those projected in the forward-looking statements.
These risks include, but are not limited to, those associated with
the success of research and development programs, the adequacy,
timing, and results of clinical trials, the regulatory approval
process, competition, securing and maintaining corporate alliances,
market acceptance of the Company's products, the strength of
intellectual property, financing capability, the potential dilutive
effects of any financing, reliance on subcontractors and key
personnel, and other risks detailed from time-to-time in the
Company's public disclosure documents or other filings with the
Canadian and U.S. securities commissions or other securities
regulatory bodies. The forward-looking statements are made as of
the date hereof, and the Company disclaims any intention and has no
obligation or responsibility, except as required by law, to update
or revise any forward-looking statements, whether as a result of
new information, future events, or otherwise. DATASOURCE: LMS
MEDICAL SYSTEMS INC. CONTACT: Andrea Miller, Communications, LMS
Medical Systems Inc., (514) 488-3461 Ext. 222, Fax: (514) 488-1880,
E-mail: , Website: http://www.lmsmedical.com/
Copyright